Basit öğe kaydını göster

Distribution and Effects of CDKN2 p16 540 C>G and 580 C>T, and MDM2 SNP309 T>G Polymorphisms in Patients with Primary Brain Tumors.

dc.contributor.authorZEYBEK, Umit
dc.contributor.authorKemerdere, Rahşan
dc.contributor.authorKaynar, Mehmet Yaşar
dc.contributor.authorYAYLIM, İlhan
dc.contributor.authorKÜÇÜKHÜSEYİN, Özlem
dc.contributor.authorKAFADAR, Ali
dc.contributor.authorTURAN, Saime
dc.contributor.authorYENILMEZ, Ezgi Nurdan
dc.contributor.authorTUNOGLU, Servet
dc.date.accessioned2021-03-05T07:14:31Z
dc.date.available2021-03-05T07:14:31Z
dc.date.issued2015
dc.identifier.citationKAFADAR A., KÜÇÜKHÜSEYİN Ö., TURAN S., YENILMEZ E. N. , TUNOGLU S., ZEYBEK U., Kaynar M. Y. , Kemerdere R., YAYLIM İ., "Distribution and Effects of CDKN2 p16 540 C>G and 580 C>T, and MDM2 SNP309 T>G Polymorphisms in Patients with Primary Brain Tumors.", Anticancer research, cilt.35, ss.3933-42, 2015
dc.identifier.issn0250-7005
dc.identifier.othervv_1032021
dc.identifier.otherav_92c312ba-3e44-4f93-970d-73b934771ae0
dc.identifier.urihttp://hdl.handle.net/20.500.12627/98960
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84937143848&origin=inward
dc.language.isoeng
dc.titleDistribution and Effects of CDKN2 p16 540 C>G and 580 C>T, and MDM2 SNP309 T>G Polymorphisms in Patients with Primary Brain Tumors.
dc.typeMakale
dc.relation.journalAnticancer research
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume35
dc.identifier.issue7
dc.identifier.startpage3933
dc.identifier.endpage42
dc.contributor.firstauthorID112064


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster